2012
DOI: 10.1111/j.1365-4632.2011.05272.x
|View full text |Cite
|
Sign up to set email alerts
|

Approaches to the evaluation of lip hyperpigmentation

Abstract: Hyperpigmentation of the lips is a common condition. It is associated with a wide variety of conditions that include physiologic changes, genodermatoses, inflammatory diseases, endocrinologic disorders, drugs and chemicals, benign and malignant neoplasm, and other non‐melanotic conditions. The aim of this article is to provide a clinical approach to hyperpigmented lesions on the lips based on the extent of lesions, the age of onset, and associated systemic involvements. In this review, we present an algorithm … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
24
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(26 citation statements)
references
References 44 publications
(73 reference statements)
0
24
0
Order By: Relevance
“…Following this, the lesion must be stratified into either focal or nonfocal extent. For focal lesions, the morphological characteristics are the most vital to assess (to rule out neoplastic lesions), while age‐of‐onset and evaluation for systemic involvement is of greatest importance in establishing a diagnosis for multiple or diffuse lesions . Entities that commonly result in multiple hyperpigmented lesions of the lip include Peutz‐Jeghers syndrome, Addison's disease, Albright's syndrome, lentigo simplex, solar lentigos, and functional melanocytic nevi.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Following this, the lesion must be stratified into either focal or nonfocal extent. For focal lesions, the morphological characteristics are the most vital to assess (to rule out neoplastic lesions), while age‐of‐onset and evaluation for systemic involvement is of greatest importance in establishing a diagnosis for multiple or diffuse lesions . Entities that commonly result in multiple hyperpigmented lesions of the lip include Peutz‐Jeghers syndrome, Addison's disease, Albright's syndrome, lentigo simplex, solar lentigos, and functional melanocytic nevi.…”
Section: Discussionmentioning
confidence: 99%
“…Entities that commonly result in multiple hyperpigmented lesions of the lip include Peutz‐Jeghers syndrome, Addison's disease, Albright's syndrome, lentigo simplex, solar lentigos, and functional melanocytic nevi. Diffuse involvement without systemic systems, as in the case of the patient above, is common in smokers, but can also be seen with certain drugs, drug eruptions, Laugier‐Hunziker syndrome, and as a normal racial variant . In the case of the patient above, lip hyperpigmentation was most likely the latter, as work‐up revealed no systemic symptoms and she was not a smoker.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to the benign nature of the disease, it is critical to differentiate this disorder from conditions with similar mucocutaneous pigmentary changes with somatic abnormalities that require medical attention [12]. The differential diagnosis considered for this adult patient with hyperpigmentation of fingers and lips included medication-induced, exposures to heavy metals, Addison’s disease, and rare genetic syndromes such as Peutz-Jeghers syndrome (PJS).…”
Section: Discussionmentioning
confidence: 99%
“…Drugs may cause a post inflammatory hyperpigmentation that is a typical non-specific reaction of fixed drug reactions. Hyperpigmentation of the lips is a common presentation in clinical practice that require a systematic approach for the diagnostic that includes a complete medical history, family history, history of cosmetic and medication use, and evaluation of systemic symptoms (30). The list of medications that can cause lip or oral hyperpigmentation include sulphonamides, nonsteroidal anti-inflammatory drugs, carbamacepine, phenothiazines, minocycline, zidovudine, cyclophosphamide, doxorubicin, escitalopram, levodopa, nicotine, tacrolimus, cotrimazole, colchicines, ketoconazole, pyrimethamine and barbiturates (30,31).…”
Section: Discussionmentioning
confidence: 99%